International consensus guideline (54 experts, 18 countries; 32 recommendations, 29 strong) advises offering curative-intent multimodality treatment to fit patients with de novo metastatic nasopharyngeal carcinoma and ≤3 lesions in ≤2 organs.
Guideline
Guo et al. Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations